Compounded tirzepatide cost per dose
What compounded tirzepatide costs at each titration stage — and why flat, dose-independent pricing usually beats escalating models over a year.
Compounded tirzepatide cost per dose
You typically start at 2.5 mg and step up. With flat-rate pricing the cost is identical at every stage; escalating models rise as you climb.
| Dose stage | Flat-rate (NexLife) | Typical escalating model |
|---|---|---|
| 2.5 mg (month 1) | $186 (flat) | $199 (escalating, illustrative) |
| 5 mg | $186 | $249 |
| 7.5 mg | $186 | $329 |
| 10 mg | $186 | $399 |
| 12.5 mg | $186 | $449 |
| 15 mg | $186 | $449+ |
Illustrative escalating figures; verify with each provider. See the per-dose pages for 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
Questions
Does compounded tirzepatide cost more at higher doses?
With flat-rate pricing, no — the monthly cost is the same from 2.5 mg to 15 mg. Escalating models charge more as the dose increases. See NexLife pricing
Which dose will I be on?
Most patients titrate from 2.5 mg upward over months toward a maintenance dose chosen by their clinician. Compounded tirzepatide is not FDA-approved.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.